Salesforce Stock Finds Support as AI Momentum Builds
It has taken time, but ’s bottom has been reached, and the stage is set for a robust rebound. The SaaS apocalypse is not happening; ...
Read moreLook Forward, Move Forward – Reporting on the cutting edge developments leading the way.
It has taken time, but ’s bottom has been reached, and the stage is set for a robust rebound. The SaaS apocalypse is not happening; ...
Read moreImmunityBio IBRX enters the post-earnings stretch with the stock at $7.72 (as of May 28, 2026) and a six to12 month price target of $8.25. ...
Read moreLooking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Enliven Therapeutics Inc (Symbol: ELVN), where a ...
Read moreImmunityBio IBRX is trying to turn a persistent bottleneck in bladder cancer care into a durable demand driver. The long-running U.S. Bacillus Calmette-Guérin (BCG) shortage ...
Read moreKey Points SpaceX spent $12.7 billion on AI last year, and capital expenditures are rising even faster this year. The company believes these early investments ...
Read moreSnowflake SNOW used its first-quarter fiscal 2027 call to make a broader point than a simple earnings beat. Management argued that the company is moving ...
Read moreKey Points Two of the hottest stocks in the market right now are Advanced Micro Devices (NASDAQ: AMD) and Micron (NASDAQ: MU). And according to ...
Read moreCostco Wholesale Corporation COST used its fiscal third-quarter call to stress a familiar point with sharper urgency: in a volatile consumer and cost environment, management ...
Read moreA former floor trader reveals the framework he uses to spot potential breakout trades early and the stock his system is flagging right now. Listen ...
Read moreKey Points When Cathie Wood makes a move, investors take notice. That’s because the chief executive officer of Ark Invest has a good eye for ...
Read more